Indrayani Biotech Ltd vs Marico Ltd

A side-by-side comparison of Indrayani Biotech Ltd (INDRANIB) and Marico Ltd (MARICO) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Marico Ltd leads INDRANIB vs MARICO on 10 of 14 metrics (2 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

9.56
P/E ratio
62.90
0.49
P/B ratio
26.51
0.00%
Dividend yield
0.47%
₹0.81
EPS
₹13.57

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

-6.11%
Return on equity
43.00%
14.00%
Return on capital
47.00%
14.00%
EBITDA margin
17.00%
6.06%
Net margin
13.32%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

Revenue CAGR (3Y)
11.71%
Profit CAGR (3Y)
11.10%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹63 Cr
Market cap
₹1.11L Cr
₹165 Cr
Revenue
₹13,611 Cr
₹10 Cr
Net profit
₹1,813 Cr
1.88
Debt / equity
0.13
Indrayani Biotech Ltd
  • + ["Stock is trading at 0.81 times its book value", "Company is expected to give good quarter"]
  • ["Company has low interest coverage ratio.", "Promoter holding is low: 33.3%", "Company has a low return on equity of 5.79% over last 3 years.", "Earnings include an other income of Rs.6.47 Cr.", "Company has high debtors of 165 days.", "Promoter holding has decreased over last 3 years: -11.6%", "Working capital days have increased from 114 days to 211 days"]
Marico Ltd
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 40.9%", "Company has been maintaining a healthy dividend payout of 65.1%"]
  • ["Stock is trading at 26.0 times its book value", "The company has delivered a poor sales growth of 11.1% over past five years."]
Indrayani Biotech Ltd full analysis Marico Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.